Transforming NASH Care: How Novel Drug Classes Are Leading the Way | #non-Alcoholic Steatohepatitis # Non-Alcoholic Steatohepatitis Market # Non-Alcoholic Steatohepatitis Forecast # Non-Alcoholic Steatohepatitis Companies # Non-Alcoholic Steatohepatitis Therapies # Non-Alcoholic Steatohepatitis Epidemiology # Non-Alcoholic Steatohepatitis Pipeline # Non-Alcoholic Steatohepatitis Market Size # Non-Alcoholic Steatohepatitis Market Trends

Science and Technology

Transforming NASH Care: How Novel Drug Classes Are Leading the Way

Non-alcoholic steatohepatitis (NASH) is a severe liver disease characterized by inflammation and fat accumulation in the liver, often leading to cirrhosis, liver failure, and an increased risk of liver cancer. NASH is a growing global health concern, with the rising prevalence of obesity,